Tuberculosis, Lung Health and Respiratory Diseases

Multidrug-Resistant Tuberculosis (MDR-TB) and Novel Therapies

This track focuses on the growing challenge of multidrug-resistant tuberculosis (MDR-TB) and the development of novel therapies. Experts will discuss the mechanisms of drug resistance, challenges in treatment adherence, and innovative therapeutic approaches, including new drug combinations and shorter treatment regimens. Attendees will gain valuable insights into global initiatives aimed at controlling MDR-TB and ensuring equitable access to effective treatment.